215 related articles for article (PubMed ID: 35766333)
1. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer.
Zhao H; Zhang S; Shao S; Fang H
Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296
[No Abstract] [Full Text] [Related]
7. Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma.
Du JW; Li GQ; Li YS; Qiu XG
Sci Rep; 2021 Aug; 11(1):16239. PubMed ID: 34376710
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma.
Wu P; Shi J; Sun W; Zhang H
Bioengineered; 2021 Dec; 12(2):12854-12866. PubMed ID: 34898340
[TBL] [Abstract][Full Text] [Related]
11. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
13. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
Wang Y; Zhang Y; Li Y; Huang J
Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
[TBL] [Abstract][Full Text] [Related]
15. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
16. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
17. A biomarker and molecular mechanism investigation for thyroid cancer.
Xie K
Cent Eur J Immunol; 2023; 48(3):203-218. PubMed ID: 37901864
[TBL] [Abstract][Full Text] [Related]
18. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the
Zou S; Ye J; Hu S; Wei Y; Xu J
Int J Gen Med; 2022; 15():19-31. PubMed ID: 35018111
[TBL] [Abstract][Full Text] [Related]
20. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
